Shionogi

Shionogi

Japan; Osaka Japan; Osaka Osaka Japan; East Asia
Is it you?
Investor info
Type
Corporate Venture Capital
Stage focus
  • Seed Round,
  • Early stage VC
Geography focus
Japan; United States; Europe; Asia
Industry focus
Description
Shionogi is the corporate venture capital arm of Japan-based pharmaceutical company SHIONOGI, established in April 2025 to back startups that can create strategic breakthroughs for its 2030–2040 growth. It invests from seed through mid-stage opportunities across Japan, the United States, Europe and Asia, with focus areas including biotechnology, life sciences, healthtech, pharmaceuticals, AI and deep tech. Its annual investment budget is about $14 million.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Biotechnology
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.